SOHO Italy 1st School of Multiple Myeloma
C

Single-Cell Characterization of the BM Immune Microenvironment in MM: Genomics of SMM, MGUS to Myeloma, CD27-T-Cells as Source of Tumor-Reactive Lymphocytes, Immune-Cell Subsets, Neo-Antigens

By SOHO Italy 1st School of Multiple Myeloma FEATURING Cirino Botta
By SOHO Italy 1st School of Multiple Myeloma FEATURING Cirino Botta
27 views
February 5, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
03:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Highlights From the International Myeloma S…

Feat. J. Richter
23:34
MyCancerHaven

Experts Discuss the Diagnosis and Management of High-Risk Multiple M…

Feat. R. Vij, M. Alsina
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
42:37
University of Colorado Department of Medicine

Multiple Myeloma in 2023: An Oncological Success Story

Feat. P. Forsberg
04:34
Icahn School of Medicine at Mount Sinai

Revisiting the Role of Alkylating Agents in Myeloma: Up-to-Date Evid…

Feat. J. Richter
10:32
Penn Medicine Abramson Cancer Center

Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…

Feat. A. Garfall
27:06
Moffitt Cancer Center

Hot Off the Press: Experts Discuss the Latest Data in Plasma Cell Dy…

Feat. R. Baz, M. Alsina, K. Shain, A. Grajales-Cruz
47:07
Louisville Hematology Highlights

Updates on the Progress in Multiple Myeloma

Feat. D. Reece
26:08
GRACE

2023 Updates on Advances in Multiple Myeloma

Feat. S. Kumar
10:25
5th SOHO Italy Annual Conference

SOHO Italy 2023: Is It Time for a Biomarkers-Driven Approach in Smol…

Feat. I. Ghobrial
20:28
Dana-Farber Cancer Institute

The PROMISE of Early Detection and Interception in Myeloma

Feat. I. Ghobrial
15:28
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Next Generation Therapeutics (Degraders & Targeted Th…

Feat. A. Nooka
26:58
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Feat. S. Susanibar-Adaniya
44:53
MyCancerHaven

Experts Discuss MGUS and Smoldering Myeloma

Feat. R. Vij, P. Kapoor
12:32
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Early Benefits and Psychological Effects of…

Feat. S. Rögnvaldsson
26:10
MyCancerHaven

Multiple Myeloma 101: Epidemiology, Diagnosis and Staging

Feat. R. Vij, S. Kumar
41:46
Yale Cancer Center

Early Detection and Interception in Myeloma: The PROMISE Study

Feat. I. Ghobrial
18:10
PrecisCa

Heme Tumor Board: 78 y/o Male With Newly Diagnosed Monoclonal Gammop…

Feat. D. Pollyea, A. Nooka, P. Forsberg, D. Schuster